Growing community of inventors

Milan, Italy

Mario Salmona

Average Co-Inventor Count = 4.09

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Mario Salmona ↔ Massimo Masserini (2 patents)Mario Salmona ↔ Francesca Re (2 patents)Mario Salmona ↔ Giulio Sancini (2 patents)Mario Salmona ↔ Gianluigi Forloni (2 patents)Mario Salmona ↔ Giampaolo Merlini (1 patent)Mario Salmona ↔ Luisa Diomede (1 patent)Mario Salmona ↔ Giuseppe Di Fede (0 patent)Mario Salmona ↔ Fabrizio Tagliavini (0 patent)Mario SalmonaMario Salmona (3 patents)Massimo MasseriniMassimo Masserini (3 patents)Francesca ReFrancesca Re (3 patents)Giulio SanciniGiulio Sancini (2 patents)Gianluigi ForloniGianluigi Forloni (2 patents)Giampaolo MerliniGiampaolo Merlini (1 patent)Luisa DiomedeLuisa Diomede (1 patent)Giuseppe Di FedeGiuseppe Di Fede (0 patent)Fabrizio TagliaviniFabrizio Tagliavini (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universitá Degli Studi Di Milano-Bicocca (2 from 27 patents)

2. Alterity Therapeutics Limited (1 from 4 patents)

3. Fondazione Irccs Istituto Neurologico Carlo Besta (0 patent)


3 patents:

1. 11357770 - Method of treating immunoglobulin light chain amyloidosis

2. 10010505 - Liposomes active in-vivo on neurodegenerative diseases

3. 8877236 - Liposomes active in-vivo on neurodegenerative diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…